Table S5 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection

Table S5 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection

<p>Table S5: Associations between driver mutations in BC and common risk factors</p>

Bewaard in:

Bibliografische gegevens
Hoofdauteur:	Nina Rao (15321199) (author)
Andere auteurs:	Gabriel J. Starrett (16624138) (author), Mary L. Piaskowski (17079483) (author), Kelly E. Butler (17079486) (author), Yelena Golubeva (17079489) (author), Wusheng Yan (17079492) (author), Scott M. Lawrence (17079495) (author), Michael Dean (14946283) (author), Montserrat Garcia-Closas (15035106) (author), Dalsu Baris (15321208) (author), Alison Johnson (15035103) (author), Molly Schwenn (15321211) (author), Nuria Malats (14943841) (author), Francisco X. Real (15337922) (author), Manolis Kogevinas (13368975) (author), Nathaniel Rothman (15321220) (author), Debra T. Silverman (15321223) (author), Lars Dyrskjøt (15054430) (author), Christopher B. Buck (17079498) (author), Stella Koutros (15035094) (author), Ludmila Prokunina-Olsson (15021962) (author)
Gepubliceerd in:	2025
Onderwerpen:	Cancer Cancer Biology Cancer Detection and Diagnosis Epidemiology Biomarkers Genetic biomarkers Genitourinary Cancers Bladder cancer Methodology and Modeling Viral Oncogenesis DNA tumor viruses
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items

Table S1 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
door: Nina Rao (15321199)
Gepubliceerd in: (2025)

Table S2 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
door: Nina Rao (15321199)
Gepubliceerd in: (2025)

Table S3 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
door: Nina Rao (15321199)
Gepubliceerd in: (2025)

Table S4 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
door: Nina Rao (15321199)
Gepubliceerd in: (2025)

Table S6 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
door: Nina Rao (15321199)
Gepubliceerd in: (2025)

Table S7 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
door: Nina Rao (15321199)
Gepubliceerd in: (2025)

Figure 1 from Reduction in Vaccine HPV Type Infections in a Young Women Group (18–25 Years) Five Years after HPV Vaccine Introduction in Colombia
door: Alba L. Combita (22677298)
Gepubliceerd in: (2025)

Figure 2 from Reduction in Vaccine HPV Type Infections in a Young Women Group (18–25 Years) Five Years after HPV Vaccine Introduction in Colombia
door: Alba L. Combita (22677298)
Gepubliceerd in: (2025)

Figure 3 from Reduction in Vaccine HPV Type Infections in a Young Women Group (18–25 Years) Five Years after HPV Vaccine Introduction in Colombia
door: Alba L. Combita (22677298)
Gepubliceerd in: (2025)

Figure 4 from Reduction in Vaccine HPV Type Infections in a Young Women Group (18–25 Years) Five Years after HPV Vaccine Introduction in Colombia
door: Alba L. Combita (22677298)
Gepubliceerd in: (2025)

Figure 5 from Reduction in Vaccine HPV Type Infections in a Young Women Group (18–25 Years) Five Years after HPV Vaccine Introduction in Colombia
door: Alba L. Combita (22677298)
Gepubliceerd in: (2025)

Table 1 from Reduction in Vaccine HPV Type Infections in a Young Women Group (18–25 Years) Five Years after HPV Vaccine Introduction in Colombia
door: Alba L. Combita (22677298)
Gepubliceerd in: (2025)

Table 1 from Addressing Common Misuses and Pitfalls of <i>P</i> values in Biomedical Research
door: Ming Wang (8809334)
Gepubliceerd in: (2025)

Supplementary Data from Genetic Modulation of <i>BET1L</i> Confers Colorectal Cancer Susceptibility by Reducing miRNA Binding and m<sup>6</sup>A Modification
door: Shuwei Li (16437116)
Gepubliceerd in: (2025)

Supplementary Tables from The Cytidine Deaminase APOBEC3G Contributes to Cancer Mutagenesis and Clonal Evolution in Bladder Cancer
door: Weisi Liu (14963321)
Gepubliceerd in: (2025)

Supplementary Video from The Cytidine Deaminase APOBEC3G Contributes to Cancer Mutagenesis and Clonal Evolution in Bladder Cancer
door: Weisi Liu (14963321)
Gepubliceerd in: (2025)

Supplementary Data from Profiling the Somatic Mutational Landscape of Breast Tumors from Hispanic/Latina Women Reveals Conserved and Unique Characteristics
door: Yuan Chun Ding (16721349)
Gepubliceerd in: (2025)

Supplementary Data from Genome-Wide Analysis of Rare Haplotypes Associated with Breast Cancer Risk
door: Fan Wang (14963418)
Gepubliceerd in: (2025)

Supplementary Table S1 from Additional Oncogenic Alterations in <i>RAS</i>-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
door: Athanasios Bikas (16006076)
Gepubliceerd in: (2025)

Figure 1 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
door: Erwei Zeng (14958443)
Gepubliceerd in: (2025)

Figure 2 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
door: Erwei Zeng (14958443)
Gepubliceerd in: (2025)

Figure 3 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
door: Erwei Zeng (14958443)
Gepubliceerd in: (2025)

Figure 4 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
door: Erwei Zeng (14958443)
Gepubliceerd in: (2025)

Table 1 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
door: Erwei Zeng (14958443)
Gepubliceerd in: (2025)

Supplementary Table S1 from Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer
door: Emil Christensen (15054394)
Gepubliceerd in: (2025)

Supplementary Table S2 from Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer
door: Emil Christensen (15054394)
Gepubliceerd in: (2025)

Supplementary Tables S1-S5 from Novel Genomic Risk Stratification Model for Primary Gastrointestinal Stromal Tumors (GIST) in the Adjuvant Therapy Era
door: Josephine K. Dermawan (17079555)
Gepubliceerd in: (2025)

Characterization of a Novel Porcine Circovirus Type 2a Sequence and Anti-Viral Evaluation of Matrine and Sanguinarine Combined with Network Pharmacology and Molecular Docking
door: WENTING Qiao (22587494)
Gepubliceerd in: (2025)

Supplementary Data 2 from Monitoring of Circulating Tumor DNA Predicts Response to Treatment and Early Progression in Follicular Lymphoma: Results of a Prospective Pilot Study
door: Ismael Fernández-Miranda (15051932)
Gepubliceerd in: (2025)

Supplementary Tables S1-S12 from Gene-Level Germline Contributions to Clinical Risk of Recurrence Scores in Black and White Patients with Breast Cancer
door: Achal Patel (5853731)
Gepubliceerd in: (2025)

Figure S1 from Estimation of Neutral Mutation Rates and Quantification of Somatic Variant Selection Using cancereffectsizeR
door: Jeffrey D. Mandell (14963909)
Gepubliceerd in: (2025)

Table S1-S8 from Urinary Tumor DNA MRD Analysis to Identify Responders to Neoadjuvant Immunotherapy in Muscle-invasive Bladder Cancer
door: Ruiyun Zhang (17142498)
Gepubliceerd in: (2025)

Supplementary Figure S1 from Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma
door: Sarita Paudel (15047430)
Gepubliceerd in: (2025)

Supplementary Figure S2 from Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma
door: Sarita Paudel (15047430)
Gepubliceerd in: (2025)

Supplementary Figure S3 from Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma
door: Sarita Paudel (15047430)
Gepubliceerd in: (2025)

Supplementary Figure S4 from Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma
door: Sarita Paudel (15047430)
Gepubliceerd in: (2025)

Supplementary Figure S5 from Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma
door: Sarita Paudel (15047430)
Gepubliceerd in: (2025)

Supplementary Figure S6 from Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma
door: Sarita Paudel (15047430)
Gepubliceerd in: (2025)

Supplementary Figure S1 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
door: Leon J. Wils (15055780)
Gepubliceerd in: (2025)

Supplementary Figure S10 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
door: Leon J. Wils (15055780)
Gepubliceerd in: (2025)

Cannot write session to /tmp/vufind_sessions/sess_3h538oqrhfq5a5ft0kf3r2notf